Objective: The objective of this study was to examine the usefulness of intraoperative cochlear nerve monitoring (ICNM) in the preservation of normal and social hearing in vestibular schwannoma (VS) removal. Methods: A retrospective chart review was conducted. Of 1315 patients operated for VS between June 1988 and December 2005, 150 patients were subjected to hearing preservation surgery. Among these, 99 patients with preoperative normal and social hearing (class A and B in the modified Sanna classification) and with a small tumor <1.5 cm in size were included in the analysis. The difference in hearing preservation rates between patients operated with and without ICNM was statistically examined using Fisher’s exact test. An initial analysis was conducted for the total group. Patients were then divided into two subgroups according to the surgical approach (middle cranial fossa and retrosigmoid-retrolabyrinthine). The effectiveness of ICNM in each subgroup was analyzed. Results: The hearing preservation rate was 26.7% in cases operated with ICNM and 20.8% in cases without ICNM. The difference did not reach statistical significance (p = 0.79). In subgroup analyses, the ICNM did not prove to contribute to the significantly higher hearing preservation rate. Conclusions: ICNM did not increase the ratio of patients with postoperative normal and social hearing in VS surgery.

Keywords:
Hearing preservation, Acoustic neuroma, Neuromonitoring, Middle cranial fossa, Retrosigmoid-retrolabyrinthine
1.
Cohen NL, Lewis WS, Ransohoff J: Hearing preservation in cerebellopontine angle tumor surgery: the NYU experience 1974–1991. Am J Otol 1993;14:423–433.
2.
Kveton JF, Book J: A comparison of auditory nerve monitoring techniques in acoustic tumor surgery; in Tos M, Thomsen J (eds): Acoustic Neuroma. Amsterdam, Kugler, 1992, pp 537–542.
3.
Nedzelski JM, Chiong CM, Cashman MZ, Stanton SG, Rowed DW: Hearing preservation in acoustic neuroma surgery: value of monitoring cochlear nerve action potentials. Otolaryngol Head Neck Surg1994;111:703–709.
4.
Danner C, Mastrodimos B, Cueva RA: A comparison of direct eighth nerve monitoring and auditory brainstem response in hearing preservation surgery for vestibular schwannoma. Otol Neurotol 2004;25:826–832.
5.
Jaisinghani VJ, Levine SC, Nussbaum E, Haines S, Lindgren B: Hearing preservation after acoustic neuroma surgery. Skull Base Surg 2000;10:141–147.
6.
Kanzaki J, Tos M, Sanna M, Moffat DA, Monsell EM, Berliner KI: New and modified reporting system from the consensus meeting on systems for reporting results in vestibular schwannoma. Otol Neurotol 2003;24:642–648.
7.
Rohit M, Piccirillo E, Jain Y, Augurio A, Sanna M: Preoperative predictive factors for hearing preservation in vestibular schwannoma. Ann Otol Rhinol Laryngol 2006;115:41–46.
8.
Sanna M, Khrais T, Russo A, Piccirillo E, Augurio A: Hearing preservation surgery in vestibular schwannoma: the hidden truth. Ann Otol Rhinol Laryngol 2004;113:156–163.
9.
Moller AR: Use of zero-phase digital filters to enhance brain-stem auditory evoked potential. Electroencephalogr Clin Neurophysiol 1988;71:226–232.
10.
Brackmann DE, Owens RM, Friedman RA, Hitselberger WE, De la Cruz A, House JW, et al: Prognostic factors for hearing preservation in vestibular schwannoma surgery. Am J Otol 2000;2:417–424.
11.
Kocaoglu M, Bulakbasi N, Ucoz T, Ustunsoz B, Pabuscu Y, Tayfun C, et al: Comparison of contrast-enhanced T1-weighted and 3D constructive interference in steady-state images for predicting outcome after hearing-preservation surgery for vestibular schwannoma. Neuroradiology 2003;45:476–481.
12.
Don M, Masuda A, Nelson R, Brackmann D: Successful detection of small acoustic tumors using the stacked derived-band auditory brain stem response amplitude. Am J Otol 1997;18:608–621.
13.
Yamakami I, Oka N, Yamaura A: Intraoperative monitoring of cochlear nerve compound action potential in cerebellopontine angle tumour removal. J Clin Neurosci 2003; 10:567–570.
14.
Hammerschlag PE, Berg HM, Prichep LS, John ER, Cohen NL, Ransohoff J: Real-time monitoring of brainstem auditory evoked response during cerebellopontine angle surgery. Otolaryngol Head Neck Surg 1986;95:538–542.
15.
Committee on Hearing and Equilibrium guidelines for the evaluation of hearing preservation in acoustic neuroma (vestibular schwannoma). Otolaryngol Head Neck Surg 1995;113:179–180.
16.
Hall JW, Derlacki EL: Effect of conductive hearing loss and middle ear surgery on binaural hearing. Ann Otol Rhinol Laryngol 1986;95:525–530.
17.
Valente M, Valente M, Enrietto J, Layton KM: Fitting strategies for patients with unilateral hearing loss; in Valente M (ed): Strategies for Selecting and Verifying Hearing Aid Fittings. New York, Thieme, 2002, pp 253–271.
18.
Khrasis T, Sanna M: Hearing preservation surgery in vestibular schwannoma. J Laryngol Otol 2006;120:366–370.
19.
Jackson LE, Roberson JB Jr: Acoustic neuroma surgery: use of cochlear nerve action potential monitoring for hearing preservation. Am J Otol 2000;21:249–259.
20.
Zappia JJ, Wiet RJ, O’Connor CA, Martone L: Intraoperative auditory monitoring in acoustic neuroma surgery. Otolaryngol Head Neck Surg 1996;115:104–110.
21.
Cueva R, Morris G, Priouleau G: Direct cochlear nerve monitoring: first report on a new atraumatic, self-retaining electrode. Am J Otol 1998;19:202–207.
22.
Tucker A, Slattery WH 3rd, Solcyk L, Brackmann DE: Intraoperative auditory assessments as predictors of hearing preservation after vestibular schwannoma surgery. J Am Acad Audiol 2001;12:471–477.
23.
Meyer TA, Canty PA, Wilkinson EP, Hansen MR, Rubinstein JT, Gantz BJ: Small acoustic neuromas: surgical outcomes versus observation or radiation. Otol Neurotol 2006;27:380–392.
© 2008 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.